CNMV

TDR Capital and I Squared Capital successful in bid for Applus Services S.A.

Retrieved on: 
Tuesday, April 30, 2024
Aggreko, Laboratory, Certification, TDR Capital, TDR, Partnership, EUR, CNMV, History, TIC, Renewable energy

LONDON, April 30, 2024 /PRNewswire/ -- TDR Capital and I Squared Capital are pleased to announce their successful offer for the Spanish certification company, Applus Services S.A.

Key Points: 
  • LONDON, April 30, 2024 /PRNewswire/ -- TDR Capital and I Squared Capital are pleased to announce their successful offer for the Spanish certification company, Applus Services S.A.
    Applus is one of the world's leading testing, inspection and certification (TIC) companies.
  • Applus reported revenue of €2,058 million in 2023 and employs over 26,000 people in more than 70 countries.
  • The successful bidding entity, Amber Equity Company, will now enter an acceptance period for Applus Services S.A.
  • Gary Lindsay, Managing Partner, TDR Capital, said: "TDR focuses on investing our capital and know-how in businesses with long-term secular growth opportunities like Applus.

TDR Capital and I Squared Capital successful in bid for Applus Services S.A.

Retrieved on: 
Tuesday, April 30, 2024
Aggreko, Laboratory, Certification, TDR Capital, TDR, Partnership, EUR, CNMV, History, TIC, Renewable energy

LONDON, April 30, 2024 /PRNewswire/ -- TDR Capital and I Squared Capital are pleased to announce their successful offer for the Spanish certification company, Applus Services S.A.

Key Points: 
  • LONDON, April 30, 2024 /PRNewswire/ -- TDR Capital and I Squared Capital are pleased to announce their successful offer for the Spanish certification company, Applus Services S.A.
    Applus is one of the world's leading testing, inspection and certification (TIC) companies.
  • Applus reported revenue of €2,058 million in 2023 and employs over 26,000 people in more than 70 countries.
  • The successful bidding entity, Amber Equity Company, will now enter an acceptance period for Applus Services S.A.
  • Gary Lindsay, Managing Partner, TDR Capital, said: "TDR focuses on investing our capital and know-how in businesses with long-term secular growth opportunities like Applus.

Medical technology back on track

Retrieved on: 
Wednesday, March 13, 2024
Hospital, CNMV, Growth, Annual report, TEL, Cigna, House, Health, Acceleration, Intuitive Surgical, Medtech, Post office box, SICAV, Judgement, Humana, HCA Healthcare, Congress, Environment, Lux, South, Harmony Row, Conference, AG, Medtronic, Capital, Investment, Research, Prospectus, Intelligence, SIX Swiss Exchange, CHF, Intuition, Risk, Medicare, Grand Canal Dock, Pharmaceutical industry

The broad healthcare sector and the medical technology sector, buoyed by resurgent investor interest, delivered even better returns.

Key Points: 
  • The broad healthcare sector and the medical technology sector, buoyed by resurgent investor interest, delivered even better returns.
  • “We also anticipate a big boost in growth from the increasing use of artificial intelligence in the medical technology and healthcare services industries,” Stefan Blum adds.
  • These were generally characterized by strong growth momentum in surgical procedures and an optimistic outlook for the 2024 fiscal year,” Marcel Fritsch comments.
  • Elevance, which is focused on employer-sponsored health insurance plans, reported better-than-expected profits thanks to a drop in medical costs and an increase in management’s earnings guidance for 2024.

Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund

Retrieved on: 
Wednesday, January 17, 2024
House, Research, Health care, SIX Swiss Exchange, Risk, AG, Health, Capital, Growth, Harmony Row, South, Grand Canal Dock, Lux, Post office box, Prospectus, UnitedHealth Group, Drug development, Annual report, SICAV, Investment, CNMV, OpenAI, Heart failure, Portfolio, Amgen, TEL, Judgement, PwC, USD, CHF

Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund

Key Points: 
  • Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund
    Media release of January 15, 2024
    Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund
    Generative Artificial Intelligence (GenAI) is bringing about an unprecedented technological transformation.
  • “The investment approach we are taking with the Bellevue AI Health (Lux) Fund that was launched on November 30, 2023 is different.
  • Healthcare will benefit greatly from GenAI,” says Co-Portfolio Manager Stefan Blum, which explains the rationale behind the launch of Bellevue Asset Management's latest healthcare fund.
  • The IT-related risks of implementing AI in healthcare are more calculable than in other industries because healthcare is such a highly regulated market.

Bellevue Asset Management AG: Trend reversal ahead for small and mid caps?

Retrieved on: 
Thursday, December 21, 2023
SIX Swiss Exchange, Annual report, AG, Post office box, House, CHF, University of St. Gallen, Western world, Investment, Lux, CNMV, ECB, Policy, CFA, South, Grand Canal Dock, Government, TEL, Capital, Prospectus, Harmony Row, Research, SICAV, University, War, Judgement, Risk, Pessimism, Fed, Environment, Insurance, Coronavirus, Bank, Cryptocurrency

Bellevue Asset Management AG: Trend reversal ahead for small and mid caps?

Key Points: 
  • Bellevue Asset Management AG: Trend reversal ahead for small and mid caps?
  • Trend reversal ahead for small and mid caps?
  • There is a good chance that small and mid caps will continue to gain ground over large caps.
  • Macro stability in China and the expected winding down of inventory destocking could also add some tailwind to the anticipated trend reversal in small and mid caps.

Bellevue Asset Management AG – Are healthcare stocks poised for a comeback?

Retrieved on: 
Thursday, December 21, 2023
Annual report, Post office box, Vertex Pharmaceuticals, Novo Nordisk, Investment, Capital, Intuitive Surgical, Diabetes, CRISPR Therapeutics, Montreux Healthcare Fund, SIX Swiss Exchange, ChatGPT, Acquisition, Artificial intelligence, Health care, Lux, Growth, AI, Grand Canal Dock, Eli Lilly, Economics, Judgement, Risk, University of Zurich, Clinical trial, AG, House, CNMV, Prospectus, Biotechnology, Hematology, Thermo Fisher Scientific, Doctor of Philosophy, DNA, Genome, Roche, History, Therapy, Failure, Health, D, Patient, Obesity, CHF, Medtech, South, TEL, Harmony Row, Research, SICAV, University, Federal Executive Boards, News, DSM-IV codes, Pharmaceutical industry, Medical device, Cryptocurrency, Libre, Amgen

Bellevue Asset Management AG – Are healthcare stocks poised for a comeback?

Key Points: 
  • Bellevue Asset Management AG – Are healthcare stocks poised for a comeback?
  • In his investment outlook for 2024, Cyrill Zimmermann, a member of Bellevue Asset Management’s Executive Board and Head of Healthcare Funds & Mandates, explains why it is probably only a matter of time before healthcare stocks are rediscovered by the wider investment community.
  • In view of this dynamic situation, Bellevue Asset Management launched Bellevue Obesity Solutions in November, a fund that invests in the most attractive companies across the entire value chain for obesity treatment and management.
  • Dr. Cyrill Zimmermann is Head of Healthcare Funds & Mandates and a member of the Executive Board of Bellevue Asset Management.

Bellevue Asset Management launches Obesity Solutions Fund

Retrieved on: 
Thursday, December 14, 2023
Prospectus, Disease, Nutrition, South, Overweight, Organization, Research, Risk, Capital, WHO, Diagnosis, Investment, COVID-19, Annual report, AG, Lux, Prevalence, TEL, Hospital, UNICEF, Patient, Growth, Grand Canal Dock, SIX Swiss Exchange, CHF, Post office box, SICAV, Harmony Row, Obesity, House, Judgement, CNMV, Clothing, Pharmaceutical industry, Medical device, Cryptocurrency

The Bellevue Obesity Solutions Fund opens a completely new avenue for healthcare investors,» says Christian Lach, the fund's lead portfolio manager.

Key Points: 
  • The Bellevue Obesity Solutions Fund opens a completely new avenue for healthcare investors,» says Christian Lach, the fund's lead portfolio manager.
  • It ranges from obesity prevention, diagnostics, and treatment of obesity to the treatment of myriad related health conditions.
  • Bellevue Obesity Solutions, an actively managed and global equity fund, is exclusively focused on this mega trend.
  • The portfolio management team of the Bellevue Obesity Solutions (Lux) Fund consists of Christian Lach, Lukas Leu and Oliver Kubli, all healthcare investment specialists with many years of experience.

Securitize Expands Modernization of Capital Markets into Europe

Retrieved on: 
Thursday, July 27, 2023
Spaniards, 2014 European Union bank stress test, Securitization, Banco Santander, REIT, Lawyer, Treasury, Real estate investment trust, Avalanche, International finance, European, CNMV, News, Cryptocurrency, EU, Spanish

Within this sandbox, CNMV will monitor Securitize as it issues and, later this fall, facilitates the trading and settlement of tokenized shares, consistent with the European Union's Distributed Ledger Technology Pilot Regime ( learn more ).

Key Points: 
  • Within this sandbox, CNMV will monitor Securitize as it issues and, later this fall, facilitates the trading and settlement of tokenized shares, consistent with the European Union's Distributed Ledger Technology Pilot Regime ( learn more ).
  • "European businesses will be a major beneficiary of this innovation, giving businesses a new way to raise capital through primary capital raises, and obtain potential tax benefits and liquidity through secondary trading."
  • Mancipi's goal is to raise $150 million euros and its registered advisor for this capital raise is ILP Lawyers.
  • The ability for European companies to issue shares in tokenized form is an important step in expanding business' ability to raise capital and individual investor access to the wealth generated in the private capital markets.

ESMA issues Opinion on CNMV product intervention measures

Retrieved on: 
Wednesday, July 12, 2023
National, NCA, European Securities and Markets Authority, Marketing, Article, Spanish, Element, Contract for difference, ESMA, Mercado, CNMV, Property management, EU

ESMA issues Opinion on CNMV product intervention measures

Key Points: 
  • ESMA issues Opinion on CNMV product intervention measures
    The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, has today issued an Opinion on product intervention measures taken by the Spanish Comisión Nacional del Mercado de Valores (CNMV).
  • Background
    NCAs may take product intervention measures in accordance with Article 42 of Regulation (EU) No 600/2014.
  • In accordance with Article 43 of Regulation (EU) No 600/2014, ESMA performs a facilitation and coordination role in relation to such product intervention measures taken by NCAs.
  • The opinions that ESMA previously issued on proposed national product intervention measures are published on its website.

ORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders

Retrieved on: 
Tuesday, June 27, 2023
Shareholder, Genomics, AGM, Market, ORY, Notary, ISIN, CNMV, Proxy, Annual general meeting, Management, Corporation

MADRID, Spain and BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, announced today the voting results from its Annual General Meeting (AGM) of Shareholders held on Monday, June 26, 2023, in Madrid.

Key Points: 
  • MADRID, Spain and BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, announced today the voting results from its Annual General Meeting (AGM) of Shareholders held on Monday, June 26, 2023, in Madrid.
  • A total of 20.009.878 of the issued and outstanding common shares of the Corporation (35,01%) were represented either in person or by proxy at the meeting.
  • The shareholders of the Company approved all resolutions listed below, as proposed by the Board of Directors at the Company's Annual General Meeting, with favorable votes ranging from 90% to 96%.
  • Full details of the resolutions and their independent item voting results may be examined on the Company’s web page and on the Market Regulator’s (CNMV) web page as Other Relevant Information.